Skip to main content

Table 4 Panel data estimation all markets.

From: The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors

Dependent variable: price

   
 

Model (1)

Model (2)

 

FE

RE

FE

RE

generics

0.014

0.011

  
 

(0.016)

(0.016)

  

N

  

-0.006***

-0.007***

   

(0.002)

(0.002)

Rf

0.086***

0.085***

0.089***

0.088***

 

(0.019)

(0.019)

(0.019)

(0.019)

Sm

-0.248***

-0.247***

-0.240***

-0.239***

 

(0.019)

(0.019)

(0.019)

(0.019)

Mark

-0.284***

-0.283***

-0.262***

-0.259***

 

(0.031)

(0.031)

(0.031)

(0.031)

profitc

 

-0.281

 

-0.273

  

(0.312)

 

(0.328)

clawback

-0.044**

-0.045**

-0.045**

-0.046**

 

(0.020)

(0.020)

(0.020)

(0.020)

Tax

 

0.121

 

0.087

  

(0.233)

 

(0.245)

Cea

-0.050**

-0.049**

-0.046**

-0.046**

 

(0.021)

(0.021)

(0.021)

(0.021)

constant

-1.856***

-1.883***

-1.846***

-1.866***

 

(0.042)

(0.142)

(0.042)

(0.149)

Observations

3402

3402

3402

3402

Rsq within

0.475

0.475

0.478

0.478

Rsq between

0.002

0.002

0.028

0.049

Rsq overall

0.036

0.038

0.077

0.086

Wald Chi-sq

 

2943.53

 

2989.86

F - statistic

44.88

 

45.37

 
  1. *, **, *** refer to statistical significance at the α = 1%, 5% and 10% respectively.
  2. Standard errors in parenthesis.
Back to article page

Health Economics Review

ISSN: 2191-1991

Contact us